291 related articles for article (PubMed ID: 26707048)
1. Higher serum concentrations of tyrosine and glutamate in schizophrenia patients treated with clozapine, compared to in those treated with conventional antipsychotics.
Melkersson K; Lewitt M; Hall K
Neuro Endocrinol Lett; 2015; 36(5):465-80. PubMed ID: 26707048
[TBL] [Abstract][Full Text] [Related]
2. Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses.
Melkersson KI; Hulting AL; Brismar KE
J Clin Psychiatry; 1999 Nov; 60(11):783-91. PubMed ID: 10584769
[TBL] [Abstract][Full Text] [Related]
3. Different serine and glycine metabolism in patients with schizophrenia receiving clozapine.
Hons J; Vasatova M; Cermakova E; Doubek P; Libiger J
J Psychiatr Res; 2012 Jun; 46(6):811-8. PubMed ID: 22502820
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentrations of amino acids in chronic schizophrenics treated with clozapine.
Tortorella A; Monteleone P; Fabrazzo M; Viggiano A; De Luca L; Maj M
Neuropsychobiology; 2001; 44(4):167-71. PubMed ID: 11702015
[TBL] [Abstract][Full Text] [Related]
5. Clozapine maintenance therapy in schizophrenia.
Gaszner P; Makkos Z
Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
[TBL] [Abstract][Full Text] [Related]
6. Changes in plasma D-serine, L-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment.
Yamamori H; Hashimoto R; Fujita Y; Numata S; Yasuda Y; Fujimoto M; Ohi K; Umeda-Yano S; Ito A; Ohmori T; Hashimoto K; Takeda M
Neurosci Lett; 2014 Oct; 582():93-8. PubMed ID: 25218715
[TBL] [Abstract][Full Text] [Related]
7. Clozapine as a first treatment for schizophrenia.
Woerner MG; Robinson DG; Alvir JM; Sheitman BB; Lieberman JA; Kane JM
Am J Psychiatry; 2003 Aug; 160(8):1514-6. PubMed ID: 12900316
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study.
Tiihonen J; Wahlbeck K; Lönnqvist J; Klaukka T; Ioannidis JP; Volavka J; Haukka J
BMJ; 2006 Jul; 333(7561):224. PubMed ID: 16825203
[TBL] [Abstract][Full Text] [Related]
9. Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics.
Qi LY; Xiu MH; Chen DC; Wang F; Kosten TA; Kosten TR; Zhang XY
Neurosci Lett; 2009 Sep; 462(2):113-7. PubMed ID: 19539717
[TBL] [Abstract][Full Text] [Related]
10. Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia.
Stroup TS; Gerhard T; Crystal S; Huang C; Olfson M
Am J Psychiatry; 2016 Feb; 173(2):166-73. PubMed ID: 26541815
[TBL] [Abstract][Full Text] [Related]
11. Blood biogenic amines during clozapine treatment of early-onset schizophrenia.
Schulz E; Fleischhaker C; Clement HW; Remschmidt H
J Neural Transm (Vienna); 1997; 104(10):1077-89. PubMed ID: 9503259
[TBL] [Abstract][Full Text] [Related]
12. Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics.
Evins AE; Amico ET; Shih V; Goff DC
J Neural Transm (Vienna); 1997; 104(6-7):761-6. PubMed ID: 9444574
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine.
Gama CS; Salvador M; Andreazza AC; Kapczinski F; Silva Belmonte-de-Abreu P
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):512-5. PubMed ID: 16426720
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic prescribing pathways, polypharmacy, and clozapine use in treatment of schizophrenia.
Gören JL; Meterko M; Williams S; Young GJ; Baker E; Chou CH; Kilbourne AM; Bauer MS
Psychiatr Serv; 2013 Jun; 64(6):527-33. PubMed ID: 23450334
[TBL] [Abstract][Full Text] [Related]
15. Leptin concentrations are increased in subjects treated with clozapine or conventional antipsychotics.
Hägg S; Söderberg S; Ahrén B; Olsson T; Mjörndal T
J Clin Psychiatry; 2001 Nov; 62(11):843-8. PubMed ID: 11775042
[TBL] [Abstract][Full Text] [Related]
16. Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case-control study in Finland.
Rubio JM; Kane JM; Tanskanen A; Tiihonen J; Taipale H
Lancet Psychiatry; 2024 Jun; 11(6):443-450. PubMed ID: 38697177
[TBL] [Abstract][Full Text] [Related]
17. Association between serum levels of glutamate and neurotrophic factors and response to clozapine treatment.
Krivoy A; Hochman E; Sendt KV; Hollander S; Vilner Y; Selakovic M; Weizman A; Taler M
Schizophr Res; 2018 Feb; 192():226-231. PubMed ID: 28599751
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of clozapine use in delaying hospitalization in routine clinical practice: a 2 year observational study.
Nyakyoma K; Morriss R
Psychopharmacol Bull; 2010; 43(2):67-81. PubMed ID: 21052043
[TBL] [Abstract][Full Text] [Related]
19. Serum creatine kinase levels in chronic psychosis patients--a comparison between atypical and conventional antipsychotics.
Melkersson K
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1277-82. PubMed ID: 16806625
[TBL] [Abstract][Full Text] [Related]
20. Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital.
Stone-Brown K; Naji M; Francioni A; Myers K; Samarendra H; Mushtaq-Chaudhry H; Heslop S; Sengupta S; Ross CC; Larkin F; Das M
CNS Spectr; 2016 Feb; 21(1):60-9. PubMed ID: 26726766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]